
GB40221
GPI-16552
Also known as 9-oxo-2-N,7-N-bis(3-phenylpropyl)fluorene-2,7-dicarboxamide
GPI-16552 (443794-40-9) is a novel potent inhibitor of poly(ADP-ribose) glycohydrolase (PARG), IC50=1·7 μM· Pre or post ischemia treatment (40 mg/kg) with GPI-16552 reduces brain infarct volumes in a rat model of cerebral ischemia· It modulates the inflammatory response to ischemia/reperfusion in a rat splanchnic artery occlusion model and reduces the degree of spinal cord inflammation and tissue injury after experimental spinal cord trauma· GPI-16552 synergizes with temozolomide in decreasing melanoma cell invasion and metastatic spreading in mice injected with B16 melanoma cells
- CAS number
- 443794-40-9
- Molecular weight
- 502.62
- Formula
- C33H30N2O3
- InChIKey
- OKGPGSVMCACUID-UHFFFAOYSA-N
- Catalogue number
- GB40221
- Brand
- GLPBIO
Computed properties PubChem CID 10117946 · XLogP 6.2 · TPSA 75.3 Ų · H-bond donors 2
- XLogP
- 6.2
- TPSA
- 75.3 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 10
- Heavy atoms
- 38
SMILES C1=CC=C(C=C1)CCCNC(=O)C2=CC3=C(C=C2)C4=C(C3=O)C=C(C=C4)C(=O)NCCCC5=CC=CC=C5
Computed descriptors from PubChem (CID 10117946), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il